Soy food consumption and breast cancer prognosis

Bette J. Caan, Loki Natarajan, Barbara Parker, Ellen B. Gold, Cynthia Thomson, Vicky Newman, Cheryl L. Rock, Minya Pu, Wael Al-Delaimy, John P. Pierce

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Background: Contrary to earlier clinical studies suggesting that soy may promote breast tumor growth, two recent studies show that soy-containing foods are not adversely related to breast cancer prognosis. We examined, using data from the Women's Healthy Eating and Living (WHEL) study, the effect of soy intake on breast cancer prognosis. Methods: Three thousand eighty-eight breast cancer survivors, diagnosed between 1991 and 2000 with early-stage breast cancer and participating in WHEL, were followed for a median of 7.3 years. Isoflavone intakes were measured postdiagnosis by using a food frequency questionnaire. Women self-reported new outcome events semiannually, which were then verified by medical records and/or death certificates. HRs and 95% CIs representing the association between either a second breast cancer event or death and soy intake were computed, adjusting for study group and other covariates, using the delayed entry Cox proportional hazards model. Results: As isoflavone intake increased, risk of death decreased (P for trend = 0.02). Women at the highest levels of isoflavone intake (>16.3 mg isoflavones) had a nonsignificant 54% reduction in risk of death. Conclusion: Our study is the third epidemiologic study to report no adverse effects of soy foods on breast cancer prognosis. Impact: These studies, taken together, which vary in ethnic composition (two from the United States and one from China) and by level and type of soy consumption, provide the necessary epidemiologic evidence that clinicians no longer need to advise against soy consumption for women with a diagnosis of breast cancer.

Original languageEnglish (US)
Pages (from-to)854-858
Number of pages5
JournalCancer Epidemiology Biomarkers and Prevention
Volume20
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Soy Foods
Breast Neoplasms
Isoflavones
Death Certificates
Second Primary Neoplasms
Risk Reduction Behavior
Proportional Hazards Models
Medical Records
Survivors
Epidemiologic Studies
China
Food

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Caan, B. J., Natarajan, L., Parker, B., Gold, E. B., Thomson, C., Newman, V., ... Pierce, J. P. (2011). Soy food consumption and breast cancer prognosis. Cancer Epidemiology Biomarkers and Prevention, 20(5), 854-858. https://doi.org/10.1158/1055-9965.EPI-10-1041

Soy food consumption and breast cancer prognosis. / Caan, Bette J.; Natarajan, Loki; Parker, Barbara; Gold, Ellen B.; Thomson, Cynthia; Newman, Vicky; Rock, Cheryl L.; Pu, Minya; Al-Delaimy, Wael; Pierce, John P.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 20, No. 5, 05.2011, p. 854-858.

Research output: Contribution to journalArticle

Caan, BJ, Natarajan, L, Parker, B, Gold, EB, Thomson, C, Newman, V, Rock, CL, Pu, M, Al-Delaimy, W & Pierce, JP 2011, 'Soy food consumption and breast cancer prognosis', Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 5, pp. 854-858. https://doi.org/10.1158/1055-9965.EPI-10-1041
Caan, Bette J. ; Natarajan, Loki ; Parker, Barbara ; Gold, Ellen B. ; Thomson, Cynthia ; Newman, Vicky ; Rock, Cheryl L. ; Pu, Minya ; Al-Delaimy, Wael ; Pierce, John P. / Soy food consumption and breast cancer prognosis. In: Cancer Epidemiology Biomarkers and Prevention. 2011 ; Vol. 20, No. 5. pp. 854-858.
@article{d775bb5ab316404b826139229e0c55fb,
title = "Soy food consumption and breast cancer prognosis",
abstract = "Background: Contrary to earlier clinical studies suggesting that soy may promote breast tumor growth, two recent studies show that soy-containing foods are not adversely related to breast cancer prognosis. We examined, using data from the Women's Healthy Eating and Living (WHEL) study, the effect of soy intake on breast cancer prognosis. Methods: Three thousand eighty-eight breast cancer survivors, diagnosed between 1991 and 2000 with early-stage breast cancer and participating in WHEL, were followed for a median of 7.3 years. Isoflavone intakes were measured postdiagnosis by using a food frequency questionnaire. Women self-reported new outcome events semiannually, which were then verified by medical records and/or death certificates. HRs and 95{\%} CIs representing the association between either a second breast cancer event or death and soy intake were computed, adjusting for study group and other covariates, using the delayed entry Cox proportional hazards model. Results: As isoflavone intake increased, risk of death decreased (P for trend = 0.02). Women at the highest levels of isoflavone intake (>16.3 mg isoflavones) had a nonsignificant 54{\%} reduction in risk of death. Conclusion: Our study is the third epidemiologic study to report no adverse effects of soy foods on breast cancer prognosis. Impact: These studies, taken together, which vary in ethnic composition (two from the United States and one from China) and by level and type of soy consumption, provide the necessary epidemiologic evidence that clinicians no longer need to advise against soy consumption for women with a diagnosis of breast cancer.",
author = "Caan, {Bette J.} and Loki Natarajan and Barbara Parker and Gold, {Ellen B.} and Cynthia Thomson and Vicky Newman and Rock, {Cheryl L.} and Minya Pu and Wael Al-Delaimy and Pierce, {John P.}",
year = "2011",
month = "5",
doi = "10.1158/1055-9965.EPI-10-1041",
language = "English (US)",
volume = "20",
pages = "854--858",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Soy food consumption and breast cancer prognosis

AU - Caan, Bette J.

AU - Natarajan, Loki

AU - Parker, Barbara

AU - Gold, Ellen B.

AU - Thomson, Cynthia

AU - Newman, Vicky

AU - Rock, Cheryl L.

AU - Pu, Minya

AU - Al-Delaimy, Wael

AU - Pierce, John P.

PY - 2011/5

Y1 - 2011/5

N2 - Background: Contrary to earlier clinical studies suggesting that soy may promote breast tumor growth, two recent studies show that soy-containing foods are not adversely related to breast cancer prognosis. We examined, using data from the Women's Healthy Eating and Living (WHEL) study, the effect of soy intake on breast cancer prognosis. Methods: Three thousand eighty-eight breast cancer survivors, diagnosed between 1991 and 2000 with early-stage breast cancer and participating in WHEL, were followed for a median of 7.3 years. Isoflavone intakes were measured postdiagnosis by using a food frequency questionnaire. Women self-reported new outcome events semiannually, which were then verified by medical records and/or death certificates. HRs and 95% CIs representing the association between either a second breast cancer event or death and soy intake were computed, adjusting for study group and other covariates, using the delayed entry Cox proportional hazards model. Results: As isoflavone intake increased, risk of death decreased (P for trend = 0.02). Women at the highest levels of isoflavone intake (>16.3 mg isoflavones) had a nonsignificant 54% reduction in risk of death. Conclusion: Our study is the third epidemiologic study to report no adverse effects of soy foods on breast cancer prognosis. Impact: These studies, taken together, which vary in ethnic composition (two from the United States and one from China) and by level and type of soy consumption, provide the necessary epidemiologic evidence that clinicians no longer need to advise against soy consumption for women with a diagnosis of breast cancer.

AB - Background: Contrary to earlier clinical studies suggesting that soy may promote breast tumor growth, two recent studies show that soy-containing foods are not adversely related to breast cancer prognosis. We examined, using data from the Women's Healthy Eating and Living (WHEL) study, the effect of soy intake on breast cancer prognosis. Methods: Three thousand eighty-eight breast cancer survivors, diagnosed between 1991 and 2000 with early-stage breast cancer and participating in WHEL, were followed for a median of 7.3 years. Isoflavone intakes were measured postdiagnosis by using a food frequency questionnaire. Women self-reported new outcome events semiannually, which were then verified by medical records and/or death certificates. HRs and 95% CIs representing the association between either a second breast cancer event or death and soy intake were computed, adjusting for study group and other covariates, using the delayed entry Cox proportional hazards model. Results: As isoflavone intake increased, risk of death decreased (P for trend = 0.02). Women at the highest levels of isoflavone intake (>16.3 mg isoflavones) had a nonsignificant 54% reduction in risk of death. Conclusion: Our study is the third epidemiologic study to report no adverse effects of soy foods on breast cancer prognosis. Impact: These studies, taken together, which vary in ethnic composition (two from the United States and one from China) and by level and type of soy consumption, provide the necessary epidemiologic evidence that clinicians no longer need to advise against soy consumption for women with a diagnosis of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=79955761969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955761969&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-1041

DO - 10.1158/1055-9965.EPI-10-1041

M3 - Article

VL - 20

SP - 854

EP - 858

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 5

ER -